| 000 | 01271 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250516160002.0 | ||
| 264 | 0 | _c20140310 | |
| 008 | 201403s 0 0 eng d | ||
| 022 | _a1879-0844 | ||
| 024 | 7 |
_a10.1093/eurjhf/hft109 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRichards, A Mark | |
| 245 | 0 | 0 |
_aBrain natriuretic peptide-guided management of chronic heart failure: first do no harm. _h[electronic resource] |
| 260 |
_bEuropean journal of heart failure _cAug 2013 |
||
| 300 |
_a832-4 p. _bdigital |
||
| 500 | _aPublication Type: Editorial; Comment | ||
| 650 | 0 | 4 |
_aAdrenergic beta-Antagonists _xtherapeutic use |
| 650 | 0 | 4 |
_aAngiotensin Receptor Antagonists _xtherapeutic use |
| 650 | 0 | 4 |
_aAngiotensin-Converting Enzyme Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeart Failure _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNatriuretic Peptide, Brain _xblood |
| 650 | 0 | 4 |
_aPeptide Fragments _xblood |
| 650 | 0 | 4 |
_aSodium Potassium Chloride Symporter Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aSpironolactone _xtherapeutic use |
| 773 | 0 |
_tEuropean journal of heart failure _gvol. 15 _gno. 8 _gp. 832-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/eurjhf/hft109 _zAvailable from publisher's website |
| 999 |
_c22886596 _d22886596 |
||